Ketoprofen
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- China
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- ketoprofen, profenid, orudis, oruvail
- Category
- Organic Intermediate
Wuliangye Group Yibin Pharmaceutical Co.,Ltd.
- Verified Certificate
-
9
Product name | Ketoprofen | Certification | - |
---|---|---|---|
Category | Organic Intermediate | Ingredients | - |
Keyword | ketoprofen , profenid , orudis , oruvail | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | China | Stock | - |
Supply type | - | HS code | - |
Product Information
CAS No. 22071-15-4
Synonyms:
ORUDIS; ORUVAIL; 2-(3-benzoylphenyl)-propionicaci;
2-(m-Benzoylphenyl)propionic acid;
2-(m-benzoylphenyl)propionicacid;Epatec; Profenid; Alrheumate;
m-Benzoylhydratropic acid; ISO-K; Orudis(TN)
Main functions:
Ketoprofen is generally prescribed for arthritis-related inflammatory pains or severe toothaches that result in the inflammation of the gums. Ketoprofen topical plasters are being extensively used for treatment of musculoskeletal pain. Ketoprofen can also be used for treatment of some pain, especially nerve pain such as sciatica,
postherpetic neuralgia and referred pain for radiculopathy, in the form of a cream,
ointment, liquid, spray, or gel, along with other agents which may be useful,such as cyclobenzaprine, amitriptyline, acyclovir, gabapentin, orphenadrine and other
medecines used as NSAIDs or adjuvant, atypical or potentiators for pain treatment.
Hazard codes: T: Toxic
Hazard class: 6.1(b)
Risk statements:
R25: Toxic if swallowed; R36/37/38: Irritating to eyes, respiratory system and skin
Safety statements:
26-45-36/37/39: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice; In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
EINECS(EC#): 244-759-8
Molecular formula: C16H14O3
Appearance: white or off-white crystalline powder
Density: 1.198g/cm3
Melting point: 69-71℃
Boiling point: 431.3℃ at 760mmHg
Flash point: 147℃
Water solubility: insoluble
Stability: stable at normal temperature and pressures.
Storage temperature: 0-6℃
Package: 25kg/drum
- Product Info Attached File
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Ding Fang
- Address
- Luo Long industrial zone of yibin city, Sichuan province, China
- Product Category
- Antineoplastic Agents,Cardiovascular Agents,Organic Intermediate,Pharmaceutical Intermediates
- No. of Total Employees
- 101-500
- Company introduction
-
Wuliangye Group Yibin Pharmaceutical Co.,Ltd is jointly owned by China Sinopharm (the greatest State-owned Key Enterprises) and Wuliangye group (the China Liquor King), holded by China Sinopharm. The company was established in 1969 and is located in Luo Long industrial zone of yibin city, and covers an total area of over 220000 square meters. The location is close to the Yangtse River, and has a quick link with convenient traffic by air and river, and has beautiful scenery.
Yibin Pharmaceutical Co., Ltd is a GMP approved enterprise and mainly produced formulation of Chinese medicine, APIs, biological agents, and pharmaceutical intermediates. APIs and Intermediates are our new development direction recent years ago.
With a large amount of advanced production equipments, the company has an annual total capacity of 300 tons APIs, 100 million small injections, 100 million tablets, 108 tons pills and 140 tons granules. We can expand the capacity easily according to the growing market demand.
Apart from GMP approval, the company is also ISO14001 and OHSAS18001 certified.
The company has good standard of production facilities, research and development capabilities in APIs and Intermediates. We welcome you to visit our factory, and hope to cooperate with the enterprise who has technology and market intelligence to seek win-win cooperation.
- Main Markets
-
China
India
Switzerland
U.S.A
- Main Product